Top Page
MCI Onehealth Technologies, Inc. Class A
(TSX:AIDX)
MCI Onehealth Technologies, Inc. Class A (AIDX) vs. S&P 500 (SPY)
MCI Onehealth Technologies, Inc. Class A Business Overview & Revenue Model
MCI Onehealth Technologies, Inc. Class A Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 38.97M | 7.32M | 10.42M | 47.82M | 38.57M | 46.29M | Gross Profit |
| -7.88M | 1.26M | 3.71M | 15.01M | 64.22M | 15.26M | EBIT |
| -94.44M | -17.59M | -17.55M | -16.43M | -842.00K | 523.00K | EBITDA |
| -16.44M | -16.11M | -13.94M | -11.44M | 2.11M | 3.76M | Net Income Common Stockholders |
| -27.34M | -31.60M | -21.09M | -15.67M | -1.03M | -122.00K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 9.68M | 19.16M | 1.80M | 7.68M | 1.27M | 1.52M | Total Assets |
| 125.53M | 53.70M | 45.63M | 60.89M | 22.36M | 22.68M | Total Debt |
| 22.20M | 20.93M | 17.42M | 14.35M | 15.04M | 15.95M | Net Debt |
| 12.79M | 1.77M | 16.01M | 7.21M | 14.15M | 14.82M | Total Liabilities |
| 51.86M | 32.23M | 32.13M | 31.14M | 22.12M | 20.42M | Stockholders Equity |
| 63.89M | 12.65M | 11.78M | 28.03M | 114.00K | 2.14M |
| Cash Flow | Free Cash Flow | ||||
| -23.93M | -10.86M | -9.49M | -9.47M | 3.99M | 3.09M | Operating Cash Flow |
| -22.62M | -10.80M | -8.35M | -7.10M | 4.22M | 3.21M | Investing Cash Flow |
| -15.37M | 1.35M | -1.17M | -8.64M | -234.00K | -122.00K | Financing Cash Flow |
| 28.24M | 27.20M | 3.78M | 21.99M | -4.22M | -2.89M |
MCI Onehealth Technologies, Inc. Class A Technical Analysis
MCI Onehealth Technologies, Inc. Class A Peers Comparison
MCI Onehealth Technologies, Inc. Class A Earnings Call Summary
MCI Onehealth Technologies, Inc. Class A Corporate Events
HEALWELL AI Inc. has completed the acquisition of Orion Health, a global healthcare intelligence platform, for approximately NZD$175 million. This acquisition is set to transform HEALWELL into a global leader in healthcare data interoperability and AI, enhancing its market position and enabling it to deliver improved healthcare outcomes through AI-driven insights. The acquisition is expected to bring substantial revenue synergies, operational efficiencies, and cost savings, strengthening HEALWELL’s financial profile and expanding its reach in the public sector.
HEALWELL AI Inc. announced that WELL Health Technologies Corp. intends to exercise its call option to acquire a significant portion of HEALWELL’s shares, which will coincide with HEALWELL’s acquisition of Orion Health Holdings Limited. This move will give WELL substantial economic interest and voting rights in HEALWELL, allowing it to nominate a majority of the company’s board of directors, thereby strengthening its influence and control over HEALWELL’s strategic direction.
HEALWELL AI Inc. reported a record revenue growth of 433% in 2024, reaching approximately $39 million, and anticipates further growth with the acquisition of Orion Health, a global leader in healthcare technology. The acquisition, expected to close on April 1, 2025, is set to significantly enhance HEALWELL’s market position by integrating Orion’s robust SaaS platform, which manages healthcare data for over 150 million patients worldwide, and is projected to make HEALWELL profitable on an Adjusted EBITDA basis. This strategic move, supported by substantial financing arrangements, positions HEALWELL to capitalize on expanding opportunities within the Canadian healthcare ecosystem and beyond.
HEALWELL AI Inc. reported a record revenue growth of 433% in 2024, reaching approximately $39 million, driven by strategic acquisitions and expansion in the life sciences sector. The company anticipates the transformative acquisition of Orion Health, a leader in healthcare technology, which is expected to close on April 1, 2025, and is projected to significantly enhance HEALWELL’s profitability and market positioning.
HEALWELL AI Inc. has announced it will release its financial results for the fourth quarter and year ending December 31, 2024, on March 26, 2025. The company will hold a conference call and webcast on the same day to discuss these results, reflecting its ongoing commitment to transparency and stakeholder engagement.
HEALWELL AI Inc. has secured a $50 million credit agreement led by Scotiabank and RBC to support its acquisition of Orion Health, a global healthcare intelligence platform. This agreement, along with other financing arrangements, ensures over $100 million in funding to facilitate the acquisition, marking a significant step towards closing the deal by April 1, 2025. The acquisition is expected to strengthen HEALWELL’s market position by expanding its capabilities in healthcare intelligence.
HEALWELL AI Inc. announced its participation in the upcoming Scotiabank TMT and ROTH Investor Conferences, where CEO Dr. Alexander Dobranowski will engage with investors and industry leaders. These conferences provide HEALWELL an opportunity to showcase its innovative AI-powered healthcare solutions, emphasizing its role in transforming preventative care and strengthening its industry positioning.
HEALWELL AI Inc.’s subsidiary, VeroSource Solutions Inc., has launched Digital Twin technology on its VS Data-as-a-Service Platform, offering real-time insights and advanced data visualization to optimize healthcare operations. This innovation allows healthcare managers to enhance efficiency, reduce costs, and improve patient care by simulating operations without disruption. The technology integrates various data sources, such as population demographics and disease trends, to support precise decision-making, aligning with HEALWELL’s vision of leveraging AI to improve healthcare outcomes.
HEALWELL AI Inc.’s subsidiary, Khure Health, has reported significant growth in both user adoption and partnerships with life sciences companies for its AI-powered disease detection co-pilots. In Q4-2024, Khure’s technology identified over 43,000 high-risk patients, marking a 22% increase from the previous quarter and a 500% year-over-year growth. The company has also signed four new Master Services Agreements with major pharmaceutical partners, bringing the total to 16, including collaborations with seven of the world’s top ten pharmaceutical firms. This expansion highlights Khure’s growing influence in integrating AI into healthcare workflows, aiming to improve patient outcomes through earlier disease detection.
HEALWELL AI Inc.’s subsidiary, Pentavere, has published a study in the ‘Journal of Liquid Biopsy’ validating its DARWEN™ AI platform as a leading clinical decision support tool in oncology. The study, conducted in collaboration with Princess Margaret Cancer Centre, highlights the platform’s ability to save time and improve lung cancer treatment through the use of liquid biopsies, which offer a less invasive alternative to traditional methods. By enabling fast and accurate data extraction, DARWEN™ AI is advancing personalized cancer care and precision medicine.
HEALWELL AI Inc. has received approval from the Overseas Investment Office of New Zealand to acquire Orion Health Holdings Limited, a global leader in healthcare technology. This strategic acquisition will expand HEALWELL’s capabilities by integrating Orion’s healthcare information exchange platforms and government client base, significantly enhancing its market position and operational scope.
HEALWELL AI Inc. announced a strategic cost optimization initiative aimed at achieving $3 million in annual savings to streamline operations in preparation for its acquisition of Orion Health. This initiative, which includes headcount reductions and cutting costs, is designed to maximize synergies and drive value from the acquisition, positioning the company for long-term growth. The integration of Orion is expected to bring significant cost and revenue synergies, while the company’s AI business units will continue to grow. Additionally, HEALWELL’s minimal exposure to U.S. tariffs on Canadian services positions it favorably in the current trade environment.
HEALWELL AI Inc. has successfully closed the $30 million convertible debt tranche of its $55 million bought deal financing, which will aid in funding its acquisition of Orion Health. This transaction, co-led by major financial institutions, showcases HEALWELL’s strategic expansion into international markets, potentially enhancing its industry positioning and operational capabilities.
HEALWELL AI Inc. has successfully raised $25.5 million from the equity tranche of its $55 million bought deal financing. The funds will be used for the acquisition of Orion Health, a move that positions HEALWELL to enhance its capabilities in the healthcare AI sector. The completion of the convertible debenture portion of the financing is anticipated by January 28, 2025, which will further support the strategic acquisition and growth plans.
HEALWELL AI has successfully completed the equity tranche of its $55 million bought deal financing, raising $25.5 million to fund the acquisition of Orion Health. This move aims to enhance HEALWELL’s capabilities in healthcare AI, pending the completion of the convertible debenture portion by January 28, 2025. If conditions for the acquisition are unmet, the proceeds will be returned to investors, maintaining transparency with stakeholders.